Delivery Order SPE2DB22D2206-SPE2DB25FJC67
- Not listed
- The Defense Logistics Agency (DLA) awarded a $1,360.45 delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pens on July 22, 2025, with completion expected by July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order fulfilling pharmaceutical supply needs for federal medical procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order valued at $2,586.22 to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL). This firm fixed-price delivery order is non-competitive and utilizes a competitively awarded indefinite delivery contract vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. As a major...
- The Defense Logistics Agency awarded a $2,360.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on July 25, 2025, with a completion date of July 28, 2025. This non-competitive delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the Department of Defense medical supply chain. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $1,088.36 delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pen medication on July 25, 2025, with completion targeted for July 28, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a delivery order valued at $3,938.77 to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 mL pens on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award for pharmaceutical supply to support federal medical procurement needs. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, and the product will be delivered under...
- The Defense Logistics Agency awarded a $1,360.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens. This contract was awarded competitively with no set-aside designation and has an ultimate completion date of August 11, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under a larger procurement vehicle...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency valued at $1,360.45 for the supply of Mounjaro 15 mg/0.5 ml pens, with an ultimate completion date of July 21, 2025. The award was issued on July 18, 2025, under a firm fixed-price contract type with no set-aside designation, indicating competitive procurement. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies on August 7, 2025, with completion targeted for August 8, 2025. This firm fixed-price delivery order, valued at $9,449.50, covers the supply of Mounjaro 5 mg/0.5 mL pens in 0.5 mL quantities. The award was issued on a non-set-aside basis through open competition, reflecting AmerisourceBergen's demonstrated capability to meet federal procurement standards. Performance will take...
- The Defense Logistics Agency awarded a $3,633.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pens on July 18, 2025, with completion scheduled for July 21, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at approximately $1 billion through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,904.63 on August 9, 2025, for the supply of Mounjaro 15 mg/0.5 mL pen injectors. This firm fixed-price delivery order, with an ultimate completion date of August 11, 2025, is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's competitive capability in...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJC67Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,904.63 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pens on July 28, 2025, with completion expected by July 29, 2025. This firm fixed-price delivery order, executed without set-aside designation, represents a competitive award to the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The product will be delivered to the same location, supporting the federal government's medical supply requirements through AmerisourceBergen's established distribution network. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. This prime contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The company's consistent selection as a competitively awarded federal contractor across multiple therapeutic domains demonstrates its capability to meet stringent federal procurement requirements for critical medications and medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 7/28/25 |